Semaglutide – 5mg | GLP-1 Research Peptide

Description

Semaglutide is a long-acting GLP-1 receptor agonist and one of the most researched metabolic peptides in modern preclinical pharmacology. As a synthetic analogue of human glucagon-like peptide-1 (GLP-1), semaglutide has been extensively studied in animal models for its effects on glucose-dependent insulin secretion, glucagon suppression, gastric emptying, appetite signalling, and adipose tissue metabolism.

Research into GLP-1 receptor agonists like semaglutide has expanded rapidly, with preclinical studies examining its roles in beta-cell function preservation, hypothalamic appetite regulation, hepatic lipid metabolism, and cardiovascular risk marker reduction in rodent and non-human primate models. Semaglutide’s extended half-life compared to native GLP-1 — attributed to its C-18 fatty acid chain conjugation and albumin-binding properties — makes it particularly useful in research models requiring sustained receptor activation.

Semaglutide has a molecular weight of 4,113.58 Da and the molecular formula C187H291N45O59. CAS number: 910463-68-2. Peptryn supplies semaglutide as a sterile lyophilized powder manufactured to ≥99% purity verified by HPLC and mass spectrometry. An independent US laboratory certificate of analysis is included with every batch, providing researchers with full batch data including purity, identity confirmation, and molecular weight verification.

Storage: Store lyophilized at -20°C. After reconstitution with bacteriostatic water, store at 2–8°C and use within 28 days. Protect from light.

For laboratory and in vitro research use only. Not intended for human consumption, self-administration, or veterinary use.